| Customization: | Available |
|---|---|
| Package: | 30tablets/Box |
| Composition: | Empagliflozin |
|
Still deciding? Get samples of US$ 0.1/Piece
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product | Dose | Package |
| Empagliflozin Tablets | 25mg | 30Tablets/box |
Empagliflozin Tablets belong to a class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. They are primarily used in the management of type 2 diabetes mellitus to help lower blood sugar levels by promoting the excretion of glucose in the urine. Empagliflozin helps improve glycemic control, reduce the risk of cardiovascular events, and provide additional benefits for patients with type 2 diabetes.
Empagliflozin Tablets are taken orally, usually once daily, with or without food. The dosage may vary depending on the patient's renal function, glycemic control, and individual response to treatment.
It is important to continue monitoring blood glucose levels regularly and adjust the dosage of empagliflozin as needed to achieve and maintain target glycemic goals.
Safety and Considerations:
Empagliflozin should be used with caution in patients with impaired renal function, as it may increase the risk of volume depletion, dehydration, and kidney injury. Renal function should be assessed before initiating treatment and periodically thereafter.
Patients should be advised to maintain adequate hydration and be monitored for signs and symptoms of volume depletion, including dizziness, lightheadedness, or orthostatic hypotension.
){kind=link}